Key facts
- This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Mar 2023, 16:25.
Everett Cunningham - 27 Feb 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- EXAS
- Reported as of
- 27 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2023, 16:25:46 UTC
- Prior SEC filing
- 28 Feb 2023
- Next SEC filing
- 02 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 01 Mar 2023.
Change
- Previous filing in this sequence was filed on 28 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXAS
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,677
- Change %
- +41%
- Price
- $0.000000
- Shares after
- 26,331
- Date
- 27 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXAS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,677
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 23,034
- Date
- 27 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,677
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of common stock received upon vesting of a restricted stock unit award.
Footnote F2
In addition to the shares of Common Stock reported on this Form 4, which total 26,331 shares, Mr. Cunningham also holds, in the aggregate, an additional 99,211 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of common stock.
Footnote F4
Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023.